Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CARsgen Therapeutics
Biotech
CARsgen touts phase 2 stomach cancer win for cell therapy
The trial assessed CT041-ST-01, also known as satri-cel, a cell therapy that has nabbed the attention of Moderna.
Gabrielle Masson
Jan 2, 2025 10:42am
FDA puts 3 CARsgen CAR-Ts on hold after inspecting facility
Dec 13, 2023 11:58am
Moderna plans cancer vaccine, solid tumor CAR-T combo trial
Aug 21, 2023 8:27am
Fierce Biotech launches layoff tracker—Chutes and Ladders
Apr 8, 2022 9:30am
